These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31773403)

  • 1. Evolving HIV Epidemiology in Mainland China: 2009-2018.
    Ding Y; Ma Z; He J; Xu X; Qiao S; Xu L; Shi R; Xu X; Zhu B; Li J; Wong FY; He N
    Curr HIV/AIDS Rep; 2019 Dec; 16(6):423-430. PubMed ID: 31773403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV and Aging in Mainland China: Implications for Control and Prevention Research.
    He N; Ding Y; Li J; Yuan S; Xu L; Qiao S; Xu X; Zhu B; Shi R; Barile JP; Wong FY
    Curr HIV/AIDS Rep; 2019 Dec; 16(6):439-447. PubMed ID: 31773404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of antiretroviral treatment in China: advancement and challenges.
    Luo L; Li TS
    Chin Med J (Engl); 2011 Feb; 124(3):440-4. PubMed ID: 21362348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dean Street clinics-battling London's MSM HIV epidemic.
    Kirby T; Thornber-Dunwell M
    Lancet HIV; 2018 May; 5(5):e210. PubMed ID: 29739698
    [No Abstract]   [Full Text] [Related]  

  • 5. Research on the treatment effects and drug resistances of long-term second-line antiretroviral therapy among HIV-infected patients from Henan Province in China.
    Chen J; Zhang M; Shang M; Yang W; Wang Z; Shang H
    BMC Infect Dis; 2018 Nov; 18(1):571. PubMed ID: 30442114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of HIV-1 drug resistance among antiretroviral treatment naïve individuals in mainland China: a meta-analysis.
    Su Y; Zhang F; Liu H; Smith MK; Zhu L; Wu J; Wang N
    PLoS One; 2014; 9(10):e110652. PubMed ID: 25343483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research progress on the association between HIV antiretroviral therapy and the outbreak].
    Ding ZX; Lu ZZ; Wang L; Wang N; Peng ZH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 May; 41(5):794-798. PubMed ID: 32447927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV/AIDS.
    Saag MS; Masur H
    Infect Dis Clin North Am; 2014 Sep; 28(3):xv-xvi. PubMed ID: 25151570
    [No Abstract]   [Full Text] [Related]  

  • 9. The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models.
    Blower S; Bodine E; Kahn J; McFarland W
    AIDS; 2005 Jan; 19(1):1-14. PubMed ID: 15627028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV/AIDS in Sierra Leone: Characterizing the Hidden Epidemic.
    Yendewa GA; Poveda E; Yendewa SA; Sahr F; Quiñones-Mateu ME; Salata RA
    AIDS Rev; 2018; 20(2):104-113. PubMed ID: 29938704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection.
    Krogstad PA
    J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216
    [No Abstract]   [Full Text] [Related]  

  • 12. Kept clinical visits, as scheduled in the first 6 months of antiretroviral treatment, determine long-term treatment outcomes in people living with HIV: a large retrospective cohort study in China.
    Su S; Mao L; He J; Wei X; Jing J; Chen X; Zhang L
    Sex Health; 2018 Feb; 15(1):20-28. PubMed ID: 28903015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 90-90-90 for HIV-2? Ending the HIV-2 epidemic by enhancing care and clinical management of patients infected with HIV-2.
    Gottlieb GS; Raugi DN; Smith RA
    Lancet HIV; 2018 Jul; 5(7):e390-e399. PubMed ID: 30052509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CE: Nursing in the fourth decade of the HIV epidemic.
    Starr WM; Springer LB
    Am J Nurs; 2014 Mar; 114(3):38-47; quiz 48-9. PubMed ID: 24518048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.
    Kwara A; Flanigan TP; Carter EJ
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):248-57. PubMed ID: 15786886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation and projection of the HIV epidemic trend among the migrant population in China.
    Meng X; Wang L; Chan S; Reilly KH; Peng Z; Guo W; Ding G; Ding Z; Qin Q
    Biomed Environ Sci; 2011 Aug; 24(4):343-8. PubMed ID: 22108322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the epidemiological impact of scaling up HIV testing and antiretroviral treatment in China.
    Zhang L; Gray RT; Wilson DP
    Sex Health; 2012 Jul; 9(3):261-71. PubMed ID: 22697144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression, Social Support, and Adherence to Antiretroviral Therapy Among People Living With HIV in Guangxi, China: A Longitudinal Study.
    Mao Y; Qiao S; Li X; Zhao Q; Zhou Y; Shen Z
    AIDS Educ Prev; 2019 Feb; 31(1):38-50. PubMed ID: 30742482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Drug Resistance - An Emerging Threat to Epidemic Control.
    Beyrer C; Pozniak A
    N Engl J Med; 2017 Oct; 377(17):1605-1607. PubMed ID: 29069566
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiology of HIV infection among men having sex with men in Shanghai, China.
    Zheng Y; Lu H; Jiang X; Pang M; Farthing C
    Southeast Asian J Trop Med Public Health; 2012 Sep; 43(5):1304-6. PubMed ID: 23431841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.